カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒトロタウイルスワクチン市場2022年：Rotarix、 RotaTeq、 Rotavac、 Rotavin-M1、 Lanzhou lamb、その他

◆英語タイトル：Global Human Rotavirus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8845）◆商品コード：GIR22MY8845
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：74
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ヒトロタウイルスワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒトロタウイルスワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒトロタウイルスワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・Rotarix、 RotaTeq、 Rotavac、 Rotavin-M1、 Lanzhou lamb、その他

用途別セグメントは次のように区分されます。
・病院＆クリニック、学術＆研究、その他

世界のヒトロタウイルスワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Bharat Biotech、Merck、GlaxoSmithKline

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒトロタウイルスワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒトロタウイルスワクチンメーカーの企業概要、2019年～2022年までのヒトロタウイルスワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒトロタウイルスワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒトロタウイルスワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒトロタウイルスワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒトロタウイルスワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒトロタウイルスワクチンの産業チェーンを掲載しています。
・第13、14、15章では、ヒトロタウイルスワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Bharat Biotech、Merck、GlaxoSmithKline
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：Rotarix、 RotaTeq、 Rotavac、 Rotavin-M1、 Lanzhou lamb、その他
・用途別分析2017年-2028年：病院＆クリニック、学術＆研究、その他
・ヒトロタウイルスワクチンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ヒトロタウイルスワクチンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ヒトロタウイルスワクチンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ヒトロタウイルスワクチンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ヒトロタウイルスワクチンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Rotavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Rotavirus Vaccine market size is estimated to be worth US$ 6949.3 million in 2021 and is forecast to a readjusted size of USD 10430 million by 2028 with a CAGR of 6.0% during review period. Hospitals & Clinics accounting for % of the Human Rotavirus Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Rotarix segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Rotavirus Vaccine include Bharat Biotech, Merck, GlaxoSmithKline, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Rotavirus Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Market segment by Application can be divided into
Hospitals & Clinics
Academic And Research
Others
The key market players for global Human Rotavirus Vaccine market are listed below:
Bharat Biotech
Merck
GlaxoSmithKline
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rotavirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rotavirus Vaccine, with price, sales, revenue and global market share of Human Rotavirus Vaccine from 2019 to 2022.
Chapter 3, the Human Rotavirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Rotavirus Vaccine.
Chapter 13, 14, and 15, to describe Human Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Human Rotavirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Rotavirus Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Rotavirus Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals & Clinics
1.3.3 Academic And Research
1.3.4 Others
1.4 Global Human Rotavirus Vaccine Market Size & Forecast
1.4.1 Global Human Rotavirus Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Rotavirus Vaccine Sales in Volume (2017-2028)
1.4.3 Global Human Rotavirus Vaccine Price (2017-2028)
1.5 Global Human Rotavirus Vaccine Production Capacity Analysis
1.5.1 Global Human Rotavirus Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Human Rotavirus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Rotavirus Vaccine Market Drivers
1.6.2 Human Rotavirus Vaccine Market Restraints
1.6.3 Human Rotavirus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Human Rotavirus Vaccine Product and Services
2.1.4 Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Human Rotavirus Vaccine Product and Services
2.2.4 Merck Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Human Rotavirus Vaccine Product and Services
2.3.4 GlaxoSmithKline Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Rotavirus Vaccine Breakdown Data by Manufacturer
3.1 Global Human Rotavirus Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Rotavirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Rotavirus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Human Rotavirus Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Human Rotavirus Vaccine Manufacturer Market Share in 2021
3.5 Global Human Rotavirus Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Rotavirus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Rotavirus Vaccine Market Size by Region
4.1.1 Global Human Rotavirus Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Human Rotavirus Vaccine Revenue by Region (2017-2028)
4.2 North America Human Rotavirus Vaccine Revenue (2017-2028)
4.3 Europe Human Rotavirus Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Human Rotavirus Vaccine Revenue (2017-2028)
4.5 South America Human Rotavirus Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Human Rotavirus Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Rotavirus Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Human Rotavirus Vaccine Revenue by Type (2017-2028)
5.3 Global Human Rotavirus Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Rotavirus Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Human Rotavirus Vaccine Revenue by Application (2017-2028)
6.3 Global Human Rotavirus Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Rotavirus Vaccine Sales by Type (2017-2028)
7.2 North America Human Rotavirus Vaccine Sales by Application (2017-2028)
7.3 North America Human Rotavirus Vaccine Market Size by Country
7.3.1 North America Human Rotavirus Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Human Rotavirus Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Rotavirus Vaccine Sales by Type (2017-2028)
8.2 Europe Human Rotavirus Vaccine Sales by Application (2017-2028)
8.3 Europe Human Rotavirus Vaccine Market Size by Country
8.3.1 Europe Human Rotavirus Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Rotavirus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Rotavirus Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Human Rotavirus Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Human Rotavirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Rotavirus Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Rotavirus Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Rotavirus Vaccine Sales by Type (2017-2028)
10.2 South America Human Rotavirus Vaccine Sales by Application (2017-2028)
10.3 South America Human Rotavirus Vaccine Market Size by Country
10.3.1 South America Human Rotavirus Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Human Rotavirus Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Rotavirus Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Human Rotavirus Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Human Rotavirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Rotavirus Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Rotavirus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Rotavirus Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Rotavirus Vaccine
12.3 Human Rotavirus Vaccine Production Process
12.4 Human Rotavirus Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Rotavirus Vaccine Typical Distributors
13.3 Human Rotavirus Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Human Rotavirus Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Rotavirus Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Human Rotavirus Vaccine Product and Services
Table 6. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Human Rotavirus Vaccine Product and Services
Table 10. Merck Human Rotavirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Human Rotavirus Vaccine Product and Services
Table 14. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Global Human Rotavirus Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 16. Global Human Rotavirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 17. Market Position of Manufacturers in Human Rotavirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 18. Global Human Rotavirus Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Human Rotavirus Vaccine Production Site of Key Manufacturer
Table 20. Human Rotavirus Vaccine New Entrant and Capacity Expansion Plans
Table 21. Human Rotavirus Vaccine Mergers & Acquisitions in the Past Five Years
Table 22. Global Human Rotavirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 23. Global Human Rotavirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 24. Global Human Rotavirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 25. Global Human Rotavirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 26. Global Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 27. Global Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 28. Global Human Rotavirus Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 29. Global Human Rotavirus Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 30. Global Human Rotavirus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 31. Global Human Rotavirus Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 32. Global Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 33. Global Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 34. Global Human Rotavirus Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 35. Global Human Rotavirus Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 36. Global Human Rotavirus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 37. Global Human Rotavirus Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 38. North America Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 39. North America Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 40. North America Human Rotavirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 41. North America Human Rotavirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 42. North America Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 43. North America Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 44. North America Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 45. North America Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 46. Europe Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 47. Europe Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 48. Europe Human Rotavirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 49. Europe Human Rotavirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 50. Europe Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Europe Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Europe Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Europe Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. Asia-Pacific Human Rotavirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 55. Asia-Pacific Human Rotavirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 56. Asia-Pacific Human Rotavirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 57. Asia-Pacific Human Rotavirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 58. Asia-Pacific Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. Asia-Pacific Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. Asia-Pacific Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. Asia-Pacific Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. South America Human Rotavirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 63. South America Human Rotavirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 64. South America Human Rotavirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. South America Human Rotavirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. South America Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. South America Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. South America Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. South America Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. Middle East & Africa Human Rotavirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 71. Middle East & Africa Human Rotavirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 72. Middle East & Africa Human Rotavirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 73. Middle East & Africa Human Rotavirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 74. Middle East & Africa Human Rotavirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. Middle East & Africa Human Rotavirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. Middle East & Africa Human Rotavirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Middle East & Africa Human Rotavirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Human Rotavirus Vaccine Raw Material
Table 79. Key Manufacturers of Human Rotavirus Vaccine Raw Materials
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Human Rotavirus Vaccine Typical Distributors
Table 83. Human Rotavirus Vaccine Typical Customers
List of Figures
Figure 1. Human Rotavirus Vaccine Picture
Figure 2. Global Human Rotavirus Vaccine Revenue Market Share by Type in 2021
Figure 3. Rotarix
Figure 4. RotaTeq
Figure 5. Rotavac
Figure 6. Rotavin-M1
Figure 7. Lanzhou lamb
Figure 8. Others
Figure 9. Global Human Rotavirus Vaccine Revenue Market Share by Application in 2021
Figure 10. Hospitals & Clinics
Figure 11. Academic And Research
Figure 12. Others
Figure 13. Global Human Rotavirus Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Human Rotavirus Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Human Rotavirus Vaccine Sales (2017-2028) & (K Units)
Figure 16. Global Human Rotavirus Vaccine Price (2017-2028) & (USD/Unit)
Figure 17. Global Human Rotavirus Vaccine Production Capacity (2017-2028) & (K Units)
Figure 18. Global Human Rotavirus Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Human Rotavirus Vaccine Market Drivers
Figure 20. Human Rotavirus Vaccine Market Restraints
Figure 21. Human Rotavirus Vaccine Market Trends
Figure 22. Global Human Rotavirus Vaccine Sales Market Share by Manufacturer in 2021
Figure 23. Global Human Rotavirus Vaccine Revenue Market Share by Manufacturer in 2021
Figure 24. Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Human Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Human Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Human Rotavirus Vaccine Sales Market Share by Region (2017-2028)
Figure 28. Global Human Rotavirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 29. North America Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Europe Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 32. South America Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Human Rotavirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 34. Global Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 35. Global Human Rotavirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. Global Human Rotavirus Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 37. Global Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 38. Global Human Rotavirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 39. Global Human Rotavirus Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 41. North America Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 42. North America Human Rotavirus Vaccine Sales Market Share by Country (2017-2028)
Figure 43. North America Human Rotavirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 44. United States Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 48. Europe Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 49. Europe Human Rotavirus Vaccine Sales Market Share by Country (2017-2028)
Figure 50. Europe Human Rotavirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 51. Germany Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Human Rotavirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 60. China Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 67. South America Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 68. South America Human Rotavirus Vaccine Sales Market Share by Country (2017-2028)
Figure 69. South America Human Rotavirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Human Rotavirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Human Rotavirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Human Rotavirus Vaccine in 2021
Figure 81. Manufacturing Process Analysis of Human Rotavirus Vaccine
Figure 82. Human Rotavirus Vaccine Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のヒトロタウイルスワクチン市場2022年：Rotarix、 RotaTeq、 Rotavac、 Rotavin-M1、 Lanzhou lamb、その他(Global Human Rotavirus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ウシロタウイルスワクチンのグローバル市場予測2023-2029
  • ヒト用経口ワクチンのグローバル市場予測2023-2029
  • 豚伝染性胃腸炎・豚流行性下痢・豚ロタウイルスワクチンのグローバル市場予測2023-2029
  • ヒト用ワクチンの世界市場見通し2023年-2029年
  • 世界のヒト注射インフルエンザワクチン市場インサイト及び予測（三価インフルエンザワクチン、四価インフルエンザワクチン）